Pacira Pharmaceuticals reported $96.8M in Stock for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Acelrx Pharmaceuticals ACRX:US USD 874K 27K
Aerie Pharmaceuticals AERI:US USD 46.76M 245K
Amerisourcebergen ABC:US USD 15.56B 266.97M
Astellas Pharma 4503:JP JPY 168.64B 3.81B
Bristol Myers Squibb BMY:US USD 2.07B 68M
Cara Therapeutics CARA:US USD 1.84M 1.62M
Coherus Biosciences CHRS:US USD 27.72M 4.02M
Depomed DEPO:US USD 14.27M 2.01M
Endo International Ordinary Shares ENDP:US USD 288.91M 1.16M
Heron Therapeutics HRTX:US USD 52.24M 9.08M
Horizon Pharma HZNP:US USD 190.26M 13.42M
JAZZ PHA JAZZ:US USD 728.07M 133.63M
Lannett LCI:US USD 94.12M 1.04M
Ligand Pharmaceuticals LGND:US USD 22.33M 2.45M
Nektar Therapeutics NKTR:US USD 19.06M 2.09M
Pacira Pharmaceuticals PCRX:US USD 96.8M 3.79M
Perrigo Ordinary Shares PRGO:US USD 1.09B 5.6M
Revance Therapeutics RVNC:US USD 17.18M 3.58M
Supernus Pharmaceuticals SUPN:US USD 83.16M 1.69M
Teva Pharmaceutical TEVA:IT USD 3.86B 190M
Xeris Pharmaceuticals Inc XERS:US USD 20.12M 2.23M
Zoetis ZTS:US USD 2.3B 98M